AUNIP
gene geneOn this page
Also known as MGC2603AIBp
Summary
AUNIP (aurora kinase A and ninein interacting protein, HGNC:28363) is a protein-coding gene on chromosome 1p36.11, encoding Aurora kinase A- and ninein-interacting protein (Q9H7T9). DNA-binding protein that accumulates at DNA double-strand breaks (DSBs) following DNA damage and promotes DNA resection and homologous recombination.
Enables damaged DNA binding activity. Involved in double-strand break repair via homologous recombination; negative regulation of double-strand break repair via nonhomologous end joining; and spindle organization. Located in centrosome; site of DNA damage; and spindle pole.
Source: NCBI Gene 79000 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 62 total
- MANE Select transcript:
NM_024037
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28363 |
| Approved symbol | AUNIP |
| Name | aurora kinase A and ninein interacting protein |
| Location | 1p36.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC2603, AIBp |
| Ensembl gene | ENSG00000127423 |
| Ensembl biotype | protein_coding |
| OMIM | 620397 |
| Entrez | 79000 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000374298, ENST00000481602, ENST00000538789
RefSeq mRNA: 2 — MANE Select: NM_024037
NM_001287490, NM_024037
CCDS: CCDS266, CCDS72731
Canonical transcript exons
ENST00000374298 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000872558 | 25837413 | 25837554 |
| ENSE00001155512 | 25834006 | 25835846 |
| ENSE00001463075 | 25859280 | 25859457 |
Expression profiles
Bgee: expression breadth ubiquitous, 170 present calls, max score 97.62.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.7287 / max 107.7758, expressed in 1220 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 11097 | 8.7287 | 1220 |
Top tissues by expression
280 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 97.62 | gold quality |
| secondary oocyte | CL:0000655 | 96.37 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 91.10 | gold quality |
| buccal mucosa cell | CL:0002336 | 86.57 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.00 | gold quality |
| sperm | CL:0000019 | 80.91 | gold quality |
| right testis | UBERON:0004534 | 80.60 | gold quality |
| testis | UBERON:0000473 | 79.94 | gold quality |
| left testis | UBERON:0004533 | 79.92 | gold quality |
| male germ cell | CL:0000015 | 79.34 | silver quality |
| ventricular zone | UBERON:0003053 | 73.62 | gold quality |
| ganglionic eminence | UBERON:0004023 | 71.58 | gold quality |
| bone marrow | UBERON:0002371 | 71.43 | gold quality |
| embryo | UBERON:0000922 | 71.09 | gold quality |
| bone marrow cell | CL:0002092 | 70.28 | silver quality |
| stromal cell of endometrium | CL:0002255 | 66.75 | gold quality |
| prefrontal cortex | UBERON:0000451 | 66.22 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 65.37 | silver quality |
| placenta | UBERON:0001987 | 64.87 | gold quality |
| pancreatic ductal cell | CL:0002079 | 64.23 | silver quality |
| right adrenal gland cortex | UBERON:0035827 | 64.03 | gold quality |
| cortical plate | UBERON:0005343 | 63.87 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 63.59 | gold quality |
| right adrenal gland | UBERON:0001233 | 63.36 | gold quality |
| left adrenal gland | UBERON:0001234 | 62.40 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 62.22 | gold quality |
| esophagus mucosa | UBERON:0002469 | 61.57 | gold quality |
| primary visual cortex | UBERON:0002436 | 61.56 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 61.45 | gold quality |
| monocyte | CL:0000576 | 61.12 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.61 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
56 targeting AUNIP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-6759-5P | 99.99 | 66.54 | 785 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-6793-5P | 99.97 | 65.95 | 758 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-4496 | 99.88 | 68.89 | 2236 |
| HSA-MIR-8073 | 99.86 | 65.21 | 1118 |
| HSA-MIR-383-3P | 99.85 | 65.84 | 1359 |
| HSA-MIR-4420 | 99.82 | 70.08 | 1624 |
| HSA-MIR-181B-2-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-181B-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-3934-3P | 99.76 | 65.51 | 1351 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-3175 | 99.65 | 66.30 | 2031 |
| HSA-MIR-3685 | 99.62 | 68.83 | 1621 |
| HSA-MIR-1260A | 99.61 | 66.67 | 1098 |
| HSA-MIR-1260B | 99.61 | 66.67 | 1098 |
| HSA-MIR-5004-3P | 99.54 | 68.27 | 1371 |
Literature-anchored findings (GeneRIF, showing 2)
- AIBp may not only be required for the dynamic movement of Aurora-A at the centrosomes and spindle apparatus during the cell cycle, but may also be important during brain tumorigenesis. (PMID:20596670)
- AUNIP could serve as a candidate diagnostic and prognostic biomarker for OSCC and suppression of AUNIP may be a potential approach to preventing and treating OSCC. (PMID:31409573)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Aunip | ENSMUSG00000078521 |
| rattus_norvegicus | Aunip | ENSRNOG00000022030 |
Protein
Protein identifiers
Aurora kinase A- and ninein-interacting protein — Q9H7T9 (reviewed: Q9H7T9)
All UniProt accessions (1): Q9H7T9
UniProt curated annotations — full annotation on UniProt →
Function. DNA-binding protein that accumulates at DNA double-strand breaks (DSBs) following DNA damage and promotes DNA resection and homologous recombination. Serves as a sensor of DNA damage: binds DNA with a strong preference for DNA substrates that mimic structures generated at stalled replication forks, and anchors RBBP8/CtIP to DSB sites to promote DNA end resection and ensuing homologous recombination repair. Inhibits non-homologous end joining (NHEJ). Required for the dynamic movement of AURKA at the centrosomes and spindle apparatus during the cell cycle.
Subunit / interactions. Interacts (via C-terminus) with AURKA (via C-terminus). Interacts (via N-terminus) with NIN; this interaction blocks NIN phosphorylation by both AURKA and GSK3B. Identified in a complex with NIN and AURKA. Interacts with RBBP8/CtIP.
Subcellular location. Nucleus. Chromosome. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Spindle pole.
Tissue specificity. Expressed in heart, skeletal muscles, placenta and testis.
Induction. Overexpressed in brain tumors.
Similarity. Belongs to the AUNIP family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H7T9-1 | 1 | yes |
| Q9H7T9-2 | 2 |
RefSeq proteins (2): NP_001274419, NP_076942* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029286 | AUNIP | Family |
Pfam: PF15334
UniProt features (9 total): region of interest 3, modified residue 2, chain 1, compositionally biased region 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H7T9-F1 | 51.65 | 0.02 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 267, 292
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 116 (showing top):
GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR, ELVIDGE_HYPOXIA_DN, GOBP_NEGATIVE_REGULATION_OF_DNA_REPAIR, GOBP_REGULATION_OF_DNA_REPAIR, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOCC_CENTROSOME, GOBP_REGULATION_OF_RESPONSE_TO_STRESS, GOBP_DNA_DAMAGE_RESPONSE, WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP, GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_STRESS, FISCHER_DREAM_TARGETS, GOBP_RECOMBINATIONAL_REPAIR, GOCC_SPINDLE, GOBP_CELL_CYCLE_PROCESS, GOBP_DNA_METABOLIC_PROCESS
GO Biological Process (5): double-strand break repair via homologous recombination (GO:0000724), spindle organization (GO:0007051), negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033), DNA repair (GO:0006281), DNA damage response (GO:0006974)
GO Molecular Function (3): damaged DNA binding (GO:0003684), DNA binding (GO:0003677), protein binding (GO:0005515)
GO Cellular Component (7): spindle pole (GO:0000922), nucleus (GO:0005634), centrosome (GO:0005813), site of DNA damage (GO:0090734), chromosome (GO:0005694), cytoplasm (GO:0005737), cytoskeleton (GO:0005856)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| intracellular membraneless organelle | 2 |
| recombinational repair | 1 |
| double-strand break repair | 1 |
| microtubule cytoskeleton organization | 1 |
| cell cycle process | 1 |
| double-strand break repair via nonhomologous end joining | 1 |
| negative regulation of double-strand break repair | 1 |
| regulation of double-strand break repair via nonhomologous end joining | 1 |
| DNA metabolic process | 1 |
| DNA damage response | 1 |
| cellular response to stress | 1 |
| DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| spindle | 1 |
| intracellular membrane-bounded organelle | 1 |
| centriole | 1 |
| microtubule organizing center | 1 |
| chromosome | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
702 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| AUNIP | DTL | Q9NZJ0 | 623 |
| AUNIP | LRRC74B | Q6ZQY2 | 479 |
| AUNIP | ERCC6L | Q2NKX8 | 477 |
| AUNIP | A0A087WUM3 | A0A087WUM3 | 446 |
| AUNIP | UHRF1 | Q96T88 | 441 |
| AUNIP | ANLN | Q9NQW6 | 395 |
| AUNIP | AIRIM | Q9NX04 | 369 |
| AUNIP | C6orf136 | Q5SQH8 | 349 |
| AUNIP | TAX1BP1 | Q86VP1 | 341 |
| AUNIP | ECT2 | Q9H8V3 | 340 |
| AUNIP | KDM8 | Q8N371 | 329 |
| AUNIP | ZFP69 | Q49AA0 | 324 |
| AUNIP | RPA4 | Q13156 | 316 |
| AUNIP | ZNF593 | O00488 | 311 |
| AUNIP | TENT5B | Q96A09 | 306 |
IntAct
40 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| AUNIP | TRIM68 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C14orf119 | AUNIP | psi-mi:“MI:0915”(physical association) | 0.560 |
| AUNIP | NXF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRKAB2 | AUNIP | psi-mi:“MI:0915”(physical association) | 0.560 |
| AUNIP | C14orf119 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AUNIP | DR1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AUNIP | psi-mi:“MI:0915”(physical association) | 0.560 | |
| AUNIP | FGFR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AUNIP | GSN | psi-mi:“MI:0915”(physical association) | 0.560 |
| AUNIP | HRAS | psi-mi:“MI:0915”(physical association) | 0.560 |
| AUNIP | GTF3C3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AUNIP | TRIM68 | psi-mi:“MI:0914”(association) | 0.560 |
| AURKA | WDR62 | psi-mi:“MI:0914”(association) | 0.530 |
| GRB2 | AUNIP | psi-mi:“MI:0915”(physical association) | 0.490 |
BioGRID (25): AUNIP (Affinity Capture-MS), AUNIP (Two-hybrid), AUNIP (Two-hybrid), AUNIP (Affinity Capture-MS), TRIM68 (Affinity Capture-MS), AUNIP (Two-hybrid), AUNIP (Reconstituted Complex), AUNIP (Affinity Capture-Western), AUNIP (Reconstituted Complex), AUNIP (Biochemical Activity), PRKAB2 (Two-hybrid), NXF1 (Two-hybrid), C14orf119 (Two-hybrid), AUNIP (Affinity Capture-MS), AUNIP (Affinity Capture-MS)
ESM2 similar proteins: A0JM80, A0JNH1, A0JNH9, A3KMW7, A6NMK8, A6QNQ6, B0BM16, B1H1S4, B1WC58, B2GUZ2, D3Z987, D3ZF42, E7FAP1, F6SNN2, P23497, P70347, Q0P5X5, Q14B71, Q283Q6, Q29RT4, Q2M2Z5, Q3U0P1, Q3ULM6, Q3UXL4, Q3V089, Q571C7, Q5HZI1, Q5R9I1, Q5RD97, Q5W0B1, Q6GNV6, Q6KAQ7, Q6P1D7, Q6PDM4, Q7TSY8, Q7ZZH7, Q80WQ8, Q80YR6, Q86YC2, Q8BUH8
Diamond homologs: A4IFU8, D3ZUC4, E9Q6Z5, Q9H7T9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
62 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 54 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
593 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:25837550:TGTGT:T | acceptor_gain | 1.0000 |
| 1:25859288:T:A | donor_gain | 1.0000 |
| 1:25835842:CTTTC:C | acceptor_gain | 0.9900 |
| 1:25835845:TCCTA:T | acceptor_loss | 0.9900 |
| 1:25835847:CT:C | acceptor_loss | 0.9900 |
| 1:25837407:CCATA:C | donor_loss | 0.9900 |
| 1:25837408:CATA:C | donor_loss | 0.9900 |
| 1:25837409:ATACC:A | donor_loss | 0.9900 |
| 1:25837410:TA:T | donor_loss | 0.9900 |
| 1:25837412:C:G | donor_loss | 0.9900 |
| 1:25837412:CCTGG:C | donor_gain | 0.9900 |
| 1:25837551:GTGT:G | acceptor_gain | 0.9900 |
| 1:25837555:C:CC | acceptor_gain | 0.9900 |
| 1:25839019:TCA:T | donor_gain | 0.9900 |
| 1:25846868:T:TA | donor_gain | 0.9900 |
| 1:25859275:CCCA:C | donor_loss | 0.9900 |
| 1:25859276:CCA:C | donor_loss | 0.9900 |
| 1:25859277:CA:C | donor_loss | 0.9900 |
| 1:25859278:AC:A | donor_loss | 0.9900 |
| 1:25859287:TTCC:T | donor_gain | 0.9900 |
| 1:25835843:TTTC:T | acceptor_gain | 0.9800 |
| 1:25835847:C:CC | acceptor_gain | 0.9800 |
| 1:25837551:GTGTC:G | acceptor_gain | 0.9800 |
| 1:25837552:TGT:T | acceptor_gain | 0.9800 |
| 1:25837552:TGTC:T | acceptor_loss | 0.9800 |
| 1:25837552:TGTCT:T | acceptor_gain | 0.9800 |
| 1:25837553:GT:G | acceptor_gain | 0.9800 |
| 1:25837553:GTCT:G | acceptor_gain | 0.9800 |
| 1:25837554:TC:T | acceptor_loss | 0.9800 |
| 1:25837555:C:A | acceptor_loss | 0.9800 |
AlphaMissense
2370 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:25859318:A:G | W14R | 0.978 |
| 1:25859318:A:T | W14R | 0.978 |
| 1:25835029:G:C | D346E | 0.976 |
| 1:25835029:G:T | D346E | 0.976 |
| 1:25859316:C:A | W14C | 0.973 |
| 1:25859316:C:G | W14C | 0.973 |
| 1:25835203:G:C | F288L | 0.972 |
| 1:25835203:G:T | F288L | 0.972 |
| 1:25835205:A:G | F288L | 0.972 |
| 1:25835196:C:G | D291H | 0.971 |
| 1:25835204:A:G | F288S | 0.969 |
| 1:25835031:C:G | D346H | 0.968 |
| 1:25835022:C:G | G349R | 0.967 |
| 1:25835194:A:C | D291E | 0.965 |
| 1:25835194:A:T | D291E | 0.965 |
| 1:25835030:T:G | D346A | 0.964 |
| 1:25859295:C:A | K21N | 0.959 |
| 1:25859295:C:G | K21N | 0.959 |
| 1:25835030:T:A | D346V | 0.957 |
| 1:25835195:T:G | D291A | 0.954 |
| 1:25859314:A:G | L15P | 0.954 |
| 1:25835195:T:A | D291V | 0.951 |
| 1:25835177:A:T | V297D | 0.940 |
| 1:25835030:T:C | D346G | 0.935 |
| 1:25835004:G:C | H355D | 0.933 |
| 1:25835022:C:A | G349C | 0.930 |
| 1:25837429:G:C | F68L | 0.927 |
| 1:25837429:G:T | F68L | 0.927 |
| 1:25837431:A:G | F68L | 0.927 |
| 1:25859299:A:G | L20P | 0.926 |
dbSNP variants (sampled 300 via entrez): RS1000034638 (1:25838657 C>T), RS1000106488 (1:25854076 T>A), RS1000317190 (1:25859621 C>T), RS1000335090 (1:25851848 C>T), RS1000474336 (1:25833703 G>A,T), RS1000503252 (1:25832922 A>C), RS1000529224 (1:25834098 T>C), RS1000572471 (1:25834127 A>T), RS1000637628 (1:25832672 C>T), RS1000943919 (1:25838497 C>A,G,T), RS1001010989 (1:25838743 A>C,T), RS1001246763 (1:25846399 A>G,T), RS1001794383 (1:25856036 A>G), RS1001868042 (1:25857003 C>A,T), RS1002095286 (1:25857060 G>A)
Disease associations
OMIM: gene MIM:620397 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002383_126 | Hematocrit | 3.000000e-11 |
| GCST90002384_532 | Hemoglobin | 6.000000e-12 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004348 | hematocrit |
| EFO:0004509 | hemoglobin measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
31 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression, decreases methylation | 2 |
| Acetaminophen | decreases expression, increases expression | 2 |
| Valproic Acid | affects expression, decreases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| afuresertib | decreases expression | 1 |
| lasiocarpine | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | affects expression | 1 |
| sodium arsenite | increases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| manganese chloride | increases abundance, increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | decreases expression, increases response to substance | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Calcitriol | decreases expression, affects cotreatment | 1 |
| Cisplatin | increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Estradiol | increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Manganese | increases abundance, increases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Oxygen | decreases expression | 1 |
| Testosterone | affects cotreatment, decreases expression | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_E1RL | HAP1 AUNIP (-) 2 | Cancer cell line | Male |
| CVCL_XL83 | HAP1 AUNIP (-) 1 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.